Class I
Ongoing
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
Why: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
- Company
- Fresenius Kabi USA, LLC
Lake Zurich, IL, United States - Reported
- Dec 3, 2025
- Recall started
- Nov 6, 2025
- Where sold
- Nationwide within the United States as well as AK, HI, and PR.
- Amount
- 2,199,850 vials
- Full product description
- Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
- Lots / codes affected
- Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.